Latest Articles
Genmab Announces Investigational Rinatabart Sesutecan (Rina-S®) Demonstrates Encouraging Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer in Phase 1/2 RAINFOL™-01 Trial - BioSpace
Genmab Announces Investigational Rinatabart Sesutecan (Rina-S®) Demonstrates Encouraging Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer in Phase 1/2 RAINFOL™-01 Trial BioSpace
Published: June 2, 2025, 11:48 p.m.
Genmab Announces Investigational Rinatabart Sesutecan (Rina-S®) Demonstrates Encouraging Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer in Phase 1/2 RAINFOL™-01 Trial - GlobeNewswire
Genmab Announces Investigational Rinatabart Sesutecan (Rina-S®) Demonstrates Encouraging Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer in Phase 1/2 RAINFOL™-01 Trial GlobeNewswire
Published: June 2, 2025, 6:32 p.m.
Genmab Announces Investigational Rinatabart Sesutecan (Rina-S®) Demonstrates Encouraging Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer in Phase 1/2 RAINFOL™-01 Trial - Yahoo Finance
Genmab Announces Investigational Rinatabart Sesutecan (Rina-S®) Demonstrates Encouraging Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer in Phase 1/2 RAINFOL™-01 Trial Yahoo Finance
Published: June 2, 2025, 6:30 p.m.
Genmab Announces Investigational Rinatabart Sesutecan (Rina-S®) Demonstrates Encouraging Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer in Phase 1/2 RAINFOL™-01 Trial - Yahoo
Genmab Announces Investigational Rinatabart Sesutecan (Rina-S®) Demonstrates Encouraging Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer in Phase 1/2 RAINFOL™-01 Trial Yahoo
Published: June 2, 2025, 6:30 p.m.
Adding immunotherapy to standard chemotherapy extends quality of life for patients with advanced endometrial cancer - Medical Xpress
Adding immunotherapy to standard chemotherapy extends quality of life for patients with advanced endometrial cancer Medical Xpress
Published: June 2, 2025, 6:20 p.m.
Adding immunotherapy to standard chemotherapy extends quality of life for patients with advanced endometrial cancer | Newswise - Newswise
Adding immunotherapy to standard chemotherapy extends quality of life for patients with advanced endometrial cancer | Newswise Newswise
Published: June 2, 2025, 2:25 p.m.
When doctors don’t believe their patients’ pain – experts explain the all-too-common experience of medical gaslighting - Cobb Courier
When doctors don’t believe their patients’ pain – experts explain the all-too-common experience of medical gaslighting Cobb Courier
Published: June 2, 2025, 10:07 a.m.
Advanced Age as a Predictor of Unsuccessful Bilateral Sentinel Lymph Node Detection Using Radiocolloid Mapping in Patients With Endometrial Cancer: A Prospective Observational Study - Cureus
Advanced Age as a Predictor of Unsuccessful Bilateral Sentinel Lymph Node Detection Using Radiocolloid Mapping in Patients With Endometrial Cancer: A Prospective Observational Study Cureus
Published: May 24, 2025, 12:37 a.m.
Told It’s ‘All in Your Head’? Medical Gaslighting Can Wreck Patients’ Health For Years - Study Finds
Told It’s ‘All in Your Head’? Medical Gaslighting Can Wreck Patients’ Health For Years Study Finds
Published: May 21, 2025, 9:50 p.m.
Told It’s ‘All in Your Head’? Medical Gaslighting Can Wreck Patients’ Health For Years - NewsBreak: Local News & Alerts
Told It’s ‘All in Your Head’? Medical Gaslighting Can Wreck Patients’ Health For Years NewsBreak: Local News & Alerts
Published: May 21, 2025, 5:54 p.m.
Link copied to clipboard!